Znn3bq.jpeg
±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 122  |  »Ø¸´: 1
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

yzj116

½ð³æ (ÕýʽдÊÖ)

[½»Á÷] ÐŲ»ÐÅÓÉÄã-ÎüÑÌÒ²Öβ¡

×î½ü£¬ÃÀ¹ú¼ÓÖݵĿÆÑ§¼Ò·¢ÏÖ£¬Ñ̼îÖеĴúлÎȥ¼×Ñ̼î¶ÔÓÚA betaµ°°×µÄÌÇ»ù»¯£¬»áÒÖÖÆA betaµ¼Öµİ¢¶ûÊϺ£Ä¬²¡£¨ÀÏÄê³Õ´ôÖ¢£©¡£Ô­ÀíÊÇÈ¥¼×Ñ̼î»á¹²¼ÛÐԵĸıäÌÇ»¯A betaµÄ¹¹Ïó¡£´ËÎÄÒ»³ö£¬¿ÉνÔÚamyloidÑо¿ÁìÓò¼¤Æðǧ²ãÀË
ÎÄÕÂÕªÒªÈçÏÂ
  Glycation of the amyloid beta-protein by a nicotine metabolite: a fortuitous chemical dynamic between smoking and Alzheimer's disease
The origin of Alzheimer's disease (AD) has been subjected to an intense amount of examination; however, a clear conclusion as to the nature of this crippling disease has yet to be identified. What is readily accepted is that a definitive marker of this disease is the aggregation of the amyloid beta-peptide (A beta) into neuritic plaques. The recent observation that nicotine exposure leads to delayed onset of AD has stimulated a flurry of research into the nature of this neuroprotective effect. This phenomenon has been debated, but no consensus has been reached, and although these studies have targeted nicotine, the primary alkaloid in tobacco, few studies have considered the physiological role of nicotine metabolites in disease states. Nornicotine is a major nicotine metabolite in the CNS and has been shown to participate in the aberrant glycation of proteins in vivo in a process termed nornicotine-based glycation. Herein is detailed a potentially fortuitous role of nornicotine-based glycation in relation to the pathology of AD. Specifically, nornicotine was found to covalently alter A beta, leading to reduced peptide aggregation. Potential consequences of this reaction cascade include reduced plaque formation and/or altered clearance of the peptide, as well as attenuated toxicity of soluble A beta aggregates. The findings described provide an alternative mechanism for nicotine neuroprotection in AD and a means for the alteration of amyloid folding based on a covalent chemical event
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

qywcj791

0.25

ÄÜ·­ÒëÒ»ÏÂÂ𣿿´²»¶®Ó¢ÎÄ¡£
2Â¥2006-03-20 09:11:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ yzj116 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á 348·Ö +10 °¦ÎÒ³¬ÕæÃ»ÕÐÁË 2026-04-06 10/500 2026-04-08 00:45 by JourneyLucky
[¿¼ÑÐ] 071000ÉúÎïѧ£¬Ò»Ö¾Ô¸ÉîÛÚ´óѧ296·Ö£¬Çóµ÷¼Á +12 TIckLw 2026-04-06 13/650 2026-04-07 20:34 by lijunpoly
[¿¼ÑÐ] 22408 µ÷¼Á²ÄÁÏ +7 ÎÒ½Ðez 2026-04-06 8/400 2026-04-07 17:12 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +9 ´ºÈÕÀ´ÐÅ- 2026-04-03 9/450 2026-04-07 15:17 by ¾¡Ë´Ò¢1
[ÂÛÎÄͶ¸å] Decision: Revise for Editor»¹»áËÍÉóÂð 100+3 CccccccccFD 2026-04-04 5/250 2026-04-07 10:58 by ±±¾©À³ÒðÈóÉ«
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí³µÁ¾×¨Ë¶×Ü·Ö 281 Çóµ÷¼Á +4 Éϰ¶Ñо¿Éú. 2026-04-02 4/200 2026-04-07 09:52 by ¼ÓÓÍÏòδÀ´°¡
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á +10 cs0106 2026-04-05 12/600 2026-04-06 19:41 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ÉúÎïѧѧ˶Çóµ÷¼Á£º351·ÖÒ»Ö¾Ô¸ÄϾ©Ê¦·¶´óѧÉúÎïѧרҵ +6 ¡­¡«¡¢Íõ¡­¡« 2026-04-06 7/350 2026-04-06 18:54 by macy2011
[¿¼ÑÐ] 318Çóµ÷¼Á +12 ykyhsa 2026-04-05 14/700 2026-04-06 17:46 by fuyu_
[¿¼ÑÐ] 358Çóµ÷¼Á +7 Çïgk 2026-04-04 7/350 2026-04-05 13:29 by huangmoli
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +7 dxyµ÷¼Á 2026-04-04 7/350 2026-04-05 09:15 by İÇï26
[¿¼ÑÐ] 341Çóµ÷¼Á +3 Âå¶àÂÞ 2026-04-02 4/200 2026-04-04 21:36 by ÖÇÄÜÖÇ»Û
[¿¼ÑÐ] Ò»Ö¾Ô¸¶«±±´óѧ085901ÍÁľר˶345Çóµ÷¼Á +3 zxt11111 2026-04-04 3/150 2026-04-04 14:21 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +10 @taotao 2026-04-03 10/500 2026-04-04 09:01 by T¿É¿ÉÎ÷ÀïT
[¿¼ÑÐ] 282Çóµ÷¼Á +20 ycy1201 2026-04-01 22/1100 2026-04-04 00:42 by userper
[¿¼ÑÐ] 320Çóµ÷¼Á +3 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-03 3/150 2026-04-03 11:40 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] 326Çóµ÷¼Á +10 áÌáÌ×Ð 2026-04-02 10/500 2026-04-03 09:08 by ÅÁ¶ûÂíÀ­ÌØ
[¿¼ÑÐ] 312Çóµ÷¼Á +6 ССī123 2026-04-02 7/350 2026-04-03 07:32 by jsw79
[¿¼ÑÐ] 298ÇóBÇøµ÷¼Á +4 zzz£¬£¬r 2026-04-02 5/250 2026-04-02 12:17 by ÍÁľ˶ʿÕÐÉú
[¿¼ÑÐ] 303·Ö 0807ѧ˶Çóµ÷¼Á +3 TYC3632 2026-04-01 3/150 2026-04-01 19:24 by lwk2004
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û